APP gets FDA nod for injection drug
SCHAUMBURG -- APP Pharmaceuticals Inc., a manufacturer of injectable pharmaceuticals, on Thursday announced it received approval from the U.S. Food and Drug Administration of its Polymyxin B Sulfate for injection. Polymyxin B Sulfateused is used for the treatment of acute infections.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.